144 related articles for article (PubMed ID: 641374)
1. DNA synthesis among uninvolved and involved psoriatic epidermal cells and normal epidermal cells in vitro.
Harper RA; Rispler J; Urbanek RW
J Invest Dermatol; 1978 May; 70(5):254-6. PubMed ID: 641374
[TBL] [Abstract][Full Text] [Related]
2. Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro.
Kragballe K; Desjarlais L; Marcelo CL
Br J Dermatol; 1985 Mar; 112(3):263-70. PubMed ID: 2579668
[TBL] [Abstract][Full Text] [Related]
3. Epidermal activity in the involved and uninvolved skin of patients with psoriasis.
Marks R
Br J Dermatol; 1978 Apr; 98(4):399-404. PubMed ID: 638045
[TBL] [Abstract][Full Text] [Related]
4. Circadian rhythms and differences in epidermal and in dermal cel proliferation in uninvolved and involved psoriatic skin in vivo.
Gelfant S; Ozawa A; Chalker DK; Smith JG
J Invest Dermatol; 1982 Jan; 78(1):58-62. PubMed ID: 7054307
[TBL] [Abstract][Full Text] [Related]
5. Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.
Abe J; Kondo S; Nishii Y; Kuroki T
J Clin Endocrinol Metab; 1989 Apr; 68(4):851-4. PubMed ID: 2921314
[TBL] [Abstract][Full Text] [Related]
6. Formation of epidermal cell thymocyte-activating factor (ETAF) from cultured human keratinocytes from normal and uninvolved psoriatic skin.
Kragballe K; Marcelo CL; Voorhees JJ; Sauder DN
J Invest Dermatol; 1987 Jan; 88(1):8-10. PubMed ID: 3491857
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a psoriatic skin model produced with involved or uninvolved cells.
Jean J; Leroy M; Duque-Fernandez A; Bernard G; Soucy J; Pouliot R
J Tissue Eng Regen Med; 2015 Jul; 9(7):789-98. PubMed ID: 23281213
[TBL] [Abstract][Full Text] [Related]
8. An altered response by psoriatic keratinocytes to gamma interferon.
Baker BS; Powles AV; Valdimarsson H; Fry L
Scand J Immunol; 1988 Dec; 28(6):735-40. PubMed ID: 3148190
[TBL] [Abstract][Full Text] [Related]
9. Increased cholera toxin-, and forskolin-induced cyclic AMP accumulations in psoriatic involved versus uninvolved or normal human epidermis.
Iizuka H; Matsuo S; Tamura T; Ohkuma N
J Invest Dermatol; 1988 Aug; 91(2):154-7. PubMed ID: 2456358
[TBL] [Abstract][Full Text] [Related]
10. Epidermal barrier changes in patients with psoriasis: The role of phototherapy.
Montero-Vilchez T; Soler-Góngora M; Martínez-López A; Ana FG; Buendía-Eisman A; Molina-Leyva A; Arias-Santiago S
Photodermatol Photoimmunol Photomed; 2021 Jul; 37(4):285-292. PubMed ID: 33377542
[TBL] [Abstract][Full Text] [Related]
11. Decreased high-affinity epidermal growth factor receptors in psoriatic epidermis.
Urano Y; Ikeuchi T; Fujimoto A; Asano T; Arase S; Shigemi F; Takeda K
Tokushima J Exp Med; 1989 Dec; 36(3-4):53-8. PubMed ID: 2636999
[TBL] [Abstract][Full Text] [Related]
12. Protein modifications during the keratinization of normal and psoriatic human epidermis.
Skerrow D; Hunter I
Biochim Biophys Acta; 1978 Dec; 537(2):474-84. PubMed ID: 728455
[TBL] [Abstract][Full Text] [Related]
13. Increased phospholipase C-catalyzed hydrolysis of phosphatidylinositol-4,5-bisphosphate and 1,2-sn-diacylglycerol content in psoriatic involved compared to uninvolved and normal epidermis.
Fisher GJ; Talwar HS; Baldassare JJ; Henderson PA; Voorhees JJ
J Invest Dermatol; 1990 Oct; 95(4):428-35. PubMed ID: 2170539
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the oncofetal Fn variant containing the EDA splice-in segment in the dermal-epidermal junction of psoriatic uninvolved skin.
Ting KM; Rothaupt D; McCormick TS; Hammerberg C; Chen G; Gilliam AC; Stevens S; Culp L; Cooper KD
J Invest Dermatol; 2000 Apr; 114(4):706-11. PubMed ID: 10733677
[TBL] [Abstract][Full Text] [Related]
15. A comparison between DNA synthesis and mitosis in uninvolved and involved psoriatic epidermis and normal epidermis.
Goodwin P; Hamilton S; Fry L
Br J Dermatol; 1973 Dec; 89(6):613-8. PubMed ID: 4802367
[No Abstract] [Full Text] [Related]
16. Incorporation of D-(3H)glucosamine into normal and psoriatic epidermal glycoconjugates.
King IA; Tabiowo A; Paul CJ
Br J Dermatol; 1981 Apr; 104(4):429-36. PubMed ID: 7236506
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin activities are significantly increased in both uninvolved and involved epidermis in psoriasis.
Mizumoto T; Hashimoto Y; Hirokawa M; Ohkuma N; Iizuka H; Ohkawara A
J Invest Dermatol; 1985 Nov; 85(5):450-2. PubMed ID: 2997334
[TBL] [Abstract][Full Text] [Related]
18. Abnormal proliferation of uninvolved psoriatic epidermis: differential induction by saline, propranolol, and tape stripping in vivo.
Wiley HE; Weinstein GD
J Invest Dermatol; 1979 Dec; 73(6):545-7. PubMed ID: 512406
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of transforming growth factor-alpha (TGF-alpha) and EGF receptor in transitional area of psoriatic epidermis.
Higashiyama M; Hashimoto K; Matsumoto K; Yoshikawa K
J Dermatol Sci; 1994 Feb; 7(1):45-53. PubMed ID: 7514888
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP accumulation in psoriatic skin: differential responses to histamine, AMP, and einephrine by the uninvolved and involved epidermis.
Iizuka H; Adachi K; Halprin KM; Levine V
J Invest Dermatol; 1978 May; 70(5):250-3. PubMed ID: 205616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
